Search Results - "Yoshikawa, Yukitaka"
-
1
Mechanisms of the hepatoprotective effects of tamoxifen against drug-induced and chemical-induced acute liver injuries
Published in Toxicology and applied pharmacology (01-10-2012)“…Although estrogen receptor (ER)α agonists, such as estradiol and ethinylestradiol (EE2), cause cholestasis in mice, they also reduce the degree of liver injury…”
Get full text
Journal Article -
2
Establishment of knockdown of superoxide dismutase 2 and expression of CYP3A4 cell system to evaluate drug-induced cytotoxicity
Published in Toxicology in vitro (01-09-2009)“…Drug-induced hepatotoxicity is a major problem in drug development, and oxidative stress is known as one of the causes. Superoxide dismutases (SODs) are…”
Get full text
Journal Article -
3
Knockdown of superoxide dismutase 2 enhances acetaminophen-induced hepatotoxicity in rat
Published in Toxicology (Amsterdam) (01-10-2009)“…Abstract Drug-induced hepatotoxicity is a major problem in drug development, and oxidative stress is known as one of the causes. Superoxide dismutases (SODs)…”
Get full text
Journal Article -
4
Chimeric Mice With Humanized Livers Demonstrate Human-Specific Hepatotoxicity Caused by a Therapeutic Antibody Against TRAIL-Receptor 2/Death Receptor 5
Published in Toxicological sciences (01-01-2019)“…Abstract The activation of tumor necrosis factor (TNF)-related apoptosis-inducing ligand receptor 2 (TRAIL-R2)/death receptor 5 (DR5) induces apoptosis in…”
Get full text
Journal Article -
5
Effect of antigen-dependent clearance on pharmacokinetics of anti-heparin-binding EGF-like growth factor (HB-EGF) monoclonal antibody
Published in mAbs (01-09-2014)“…Heparin-binding EGF-like growth factor (HB-EGF) is a member of the EGF family and is an important therapeutic target in some types of human cancers. KM3566 is…”
Get full text
Journal Article -
6
IL-4 mediates dicloxacillin-induced liver injury in mice
Published in Toxicology letters (05-02-2011)“…Drug-induced liver injury (DILI) is a major problem in drug development and clinical drug therapy. In most cases, the mechanisms are still unknown. It is…”
Get full text
Journal Article -
7
An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and γ-glutamylcysteine synthetase knockdown cells
Published in Toxicology in vitro (01-04-2010)“…Drug-induced hepatotoxicity is often caused by CYP-dependent activation of the drugs into reactive metabolites. CYP3A4 is one of the main isoforms involved in…”
Get full text
Journal Article -
8
Soluble heparin-binding EGF-like growth factor (HB-EGF) detected by newly developed immuno-PCR method is a clear-cut serological biomarker for ovarian cancer
Published in American journal of translational research (01-01-2012)“…Heparin-binding EGF-like growth factor (HB-EGF) is a member of the EGF family of growth factors that bind to and activate the EGF receptor. HB-EGF is…”
Get full text
Journal Article -
9
An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and I[sup3-glutamylcysteine synthetase knockdown cells
Published in Toxicology in vitro (01-04-2010)“…Drug-induced hepatotoxicity is often caused by CYP-dependent activation of the drugs into reactive metabolites. CYP3A4 is one of the main isoforms involved in…”
Get full text
Journal Article -
10
Effect of antigen-dependent clearance on pharmacokinetics of anti-heparin-binding EGF-like growth factor (HB-EGF) monoclonal antibody
Published in mAbs (03-09-2014)“…Heparin-binding EGF-like growth factor (HB-EGF) is a member of the EGF family and is an important therapeutic target in some types of human cancers. KM3566 is…”
Get full text
Report